Indogulf Cropsciences Ltd
Indogulf Cropsciences Ltd (IGCL) last traded at ₹72, a market capitalisation of ₹456 crore, on a P/E of 11.8. Over the past 52 weeks the stock has ranged between ₹49.5 and ₹119. Indogulf Cropsciences Ltd last reported results for the quarter ended Jun 2026, with sales of ₹169 crore and net profit of ₹2.41 crore. Figures are as of 25 Aug 2026 and are not real time.
Indogulf Cropsciences Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Indogulf Cropsciences Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹169 cr, down 11.0% from ₹189 cr a year earlier. Net profit was ₹2.41 cr, down 37.7% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 233 | 99.21 | 126 | 189 | 248 | 116 | 151 | 169 |
| Expenses | 205 | 89.15 | 105 | 179 | 216 | 104 | 130 | 159 |
| Operating profit | 27.43 | 10.06 | 20.85 | 9.93 | 32.01 | 11.71 | 20.37 | 9.55 |
| OPM % | 11.78% | 10.14% | 16.52% | 5.24% | 12.89% | 10.09% | 13.51% | 5.67% |
| Other income | 1.13 | 0.63 | 1.95 | 0.94 | 2.31 | 2.7 | 1.62 | 0.86 |
| Interest | 3.18 | 4.04 | 4.15 | 3.79 | 4.59 | 4.31 | 4.38 | 4.51 |
| Depreciation | 2.64 | 2.04 | 3.46 | 2.43 | 2.62 | 2.72 | 3.68 | 2.78 |
| Profit before tax | 22.74 | 4.61 | 15.19 | 4.65 | 27.11 | 7.38 | 13.93 | 3.12 |
| Tax % | 26.65% | 20.61% | 35.48% | 16.77% | 23.72% | 47.70% | 16.65% | 22.76% |
| Net profit | 16.67 | 3.66 | 9.8 | 3.87 | 20.69 | 3.86 | 11.61 | 2.41 |
| EPS (₹) | 3.42 | 0.75 | 2.01 | 0.79 | 3.27 | 0.61 | 1.84 | 0.38 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Indogulf Cropsciences Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 443 | 486 | 550 | 552 | 590 | 705 | 684 |
| Operating profit | 39 | 45 | 49 | 59 | 64 | 74 | 74 |
| OPM % | 9% | 9% | 9% | 11% | 11% | 10% | 11% |
| Net profit | 22 | 26 | 22 | 28 | 31 | 40 | 39 |
| EPS (₹) | 9.48 | 11.25 | 9.53 | 12.00 | 6.45 | 6.33 | 6.10 |
TTM is the trailing twelve months to the most recent quarter.
Indogulf Cropsciences Ltd growth and returns
- 10 Years
- %
- 5 Years
- 10%
- 3 Years
- 9%
- TTM
- 6%
- 10 Years
- %
- 5 Years
- 12%
- 3 Years
- 21%
- TTM
- 14%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- -37%
- 10 Years
- %
- 5 Years
- 13%
- 3 Years
- 12%
- Last Year
- 11%
Indogulf Cropsciences Ltd shareholding pattern
Promoters held 69.05% at Jun 2026, down from 96.86% at Jun 2025. FIIs 0.23% and DIIs 4.30%.
| % held | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Promoters | 96.86% | 69.05% | 69.05% | 69.05% | 69.05% |
| FIIs | 0.00% | 0.41% | 0.21% | 0.24% | 0.23% |
| DIIs | 0.00% | 6.23% | 4.39% | 4.36% | 4.30% |
| Public | 3.14% | 24.32% | 26.36% | 26.35% | 26.42% |
| No. of shareholders | 28 | 24,798 | 24,867 | 23,867 | 23,768 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Indogulf Cropsciences Ltd corporate filings
- Intimation under Regulation 30 of SEBI LODR is attachedCompany Updatelow impact
Cruxal's analysis: Indogulf Cropsciences Ltd has filed a routine intimation under Regulation 30 of the SEBI…
Read the full analysis - Intimation under Regulation 30 of SEBI LODR is attachedCompany Updatelow impact
Cruxal's analysis: Indogulf Cropsciences Ltd has submitted a routine intimation under Regulation 30 of the…
Read the full analysis - for the Q1 FY 26-27Company Updatemedium impact
Cruxal's analysis: Indogulf Cropsciences Limited reported a challenging Q1 FY27 with revenue from operations…
Read the full analysis - Outcome of Conference Call with Analysts / Investors - Audio RecordingCompany Updatelow impact
Cruxal's analysis: Indogulf Cropsciences Ltd has filed the audio recording of its conference call held with…
Read the full analysis - Revised Investor Presentation for the Q1 FY 2026-27Company Updatelow impact
Cruxal's analysis: Indogulf Cropsciences Limited has submitted a revised Earnings Call Presentation for Q1…
Read the full analysis - Earnings Call Presentation of the Company pertaining to Q1 FY 2026-27Company Updatehigh impact
Cruxal's analysis: Indogulf Cropsciences Limited reported a challenging Q1 FY27 with revenue from operations…
Read the full analysis - Q1 FY27 Quarterly Earnings ReleaseCompany Updatemedium impact
Cruxal's analysis: Indogulf Cropsciences reported Q1 FY27 revenue of 168.5 crore, reflecting a 12%…
Read the full analysis - Earnings Conference Call for Q1 FY 2026-27Company Updatelow impact
Cruxal's analysis: Indogulf Cropsciences Limited has announced an earnings conference call to discuss its…
Read the full analysis - for the un-audited financial results of the Company for Quarter Ended June 30, 2026Company Updatelow impact
Cruxal's analysis: Indogulf Cropsciences Limited has released its unaudited standalone and consolidated…
Read the full analysis - Financial Results for the Quarter Ended June 30, 2026Board Meetinghigh impact
Cruxal's analysis: Indogulf Cropsciences Limited reported consolidated revenue from operations of 168.55…
Read the full analysis - for the quarter ended June 30, 2026Company Updatelow impact
Cruxal's analysis: The company has filed a Monitoring Agency Report for the quarter ended June 30, 2026, in…
Read the full analysis - Indogulf Cropsciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the un-audited standalone ....Board Meetinglow impact
Cruxal's analysis: Indogulf Cropsciences Limited has formally intimated the stock exchanges regarding a…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Indogulf Cropsciences Ltd
Cruxal reads every Indogulf Cropsciences Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.